And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest this time around. We plan to hang with our short people, catch up on our reading, and perhaps take in a moving picture. And what about you? Summer is in full swing. Have you planned that getaway yet? If not, get cracking. Meanwhile, this may be a good time to enjoy the great outdoors — beaches, mountains, and parks are beckoning. You could also catch up with someone special. Or simply plan the rest of your life. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

PhRMA and several drug makers met with President Trump to voice opposition to a bipartisan Senate bill that aims to lower prescription drug prices, Reuters reports. The bill moved out of the Senate Finance committee on Thursday morning and to the floor, the next step in the legislative process. The White House, which has said it backs the legislation, has promised to bring down drug prices for U.S. consumers, an important campaign issue for Trump.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy